Fundz
Every executive departure read straight from the 8-K, filtered to the company size you serve, the morning it lands.See it live →

Ansa Biotechnologies Appoints Geoff Hamilton as Chief Financial Officer and Chief Business Officer

PRIVATEDec 09, 2025•9 months ago

Position

Chief Business Officer

Company

Ansa Biotechnologies

Geoff Hamilton
EmeryvilleBiotechnology

Description

Ansa Biotechnologies has announced the appointment of Geoff Hamilton as Chief Financial Officer and Chief Business Officer. He will lead the company's financial operations and corporate strategy as Ansa embarks on its commercial expansion in the biotechnology sector.

Company Information

Company

Ansa Biotechnologies

Location

1198 65th St, Suite 250

Emeryville, California, United States

About

Ansa Biotechnologies is redefining DNA synthesis with a bold commitment to quality, customer satisfaction, and success. The Ansa On-Time Guarantee is simple and straightforward: your complete order on time or it’s free. This unprecedented level of service reliability and predictability is made possible by Ansa’s dedicated team of experts and proprietary enzymatic synthesis platform, which can rapidly and accurately produce even the highly complex DNA elements that stymie legacy approaches. Products are delivered as sequence-perfect clonal DNA or sequence-verified linear double-stranded DNA fragments. Headquartered in Emeryville, Calif., Ansa is empowering a global community of scientists to accelerate breakthroughs in healthcare, life sciences, and other industries powered by synthetic DNA.

Don't miss Ansa Biotechnologies's next move

Get an email the moment Ansa Biotechnologies changes its leadership, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you
George McArthur
Likely contact at this company
••••••••@••••••••

See George McArthur's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Ansa Biotechnologies's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Ansa Biotechnologies changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.